Forest And Mylan Confident Nebivolol Will Reach Market In Early 2008
FDA “approvable” letter seen by firms as minor hurdle for previously delayed hypertension drug.
FDA “approvable” letter seen by firms as minor hurdle for previously delayed hypertension drug.